| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |